ScreenerHero
VTRVentas, Inc.
NYSE · US · Real Estate · REIT - Healthcare Facilities · ventasreit.com
90.67USD-1.17%Mkt Cap: 44.08B $P/E: 164.84

Ventas, Inc. is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United King…

Industry Peers

REIT - Healthcare Facilities
Screen all
WELL
Welltower Inc.
$163.48BUSDP/E 111.9
OHI
Omega Healthcare Investors, Inc.
$15.06BUSDP/E 23.3
DOC
Healthpeak Properties, Inc.
$14.93BUSDP/E 67.7
CTRE
CareTrust REIT, Inc.
$9.50BUSDP/E 25.5
HR
Healthcare Realty Trust Incorporated
$7.26BUSD
AED
Aedifica NV/SA
$6.28BUSDP/E 6.0
CSH-UN
Chartwell Retirement Residences
$5.46BUSDP/E Infinity
SBRA
Sabra Health Care REIT, Inc.
$4.95BUSDP/E 31.1
NHI
National Health Investors, Inc.
$3.65BUSDP/E 24.3
COFB
Cofinimmo SA
$3.43BUSDP/E 15.5
PHP
Primary Health Properties Plc
$2.63BUSDP/E 13.3
MPT
Medical Properties Trust, Inc.
$2.70BUSD
DHC
Diversified Healthcare Trust
$2.12BUSD
LTC
LTC Properties, Inc.
$1.99BUSDP/E 15.2
SILA
Sila Realty Trust Inc
$1.68BUSDP/E 44.6
NHP
National Healthcare Properties, Inc.
$1.11BUSD
CPINV
Care Property Invest NV
$578.96MUSDP/E 8.3
UHT
Universal Health Realty Income Trust
$597.48MUSDP/E 33.6
XRN
Chiron Real Estate Inc.
$570.92MUSD
CHCT
Community Healthcare Trust Incorporated
$514.58MUSDP/E 150.1
STRW
Strawberry Fields REIT, Inc.
$183.27MUSDP/E 21.3
Indicators:|

Key Statistics

Company
Market Cap44.08B $
Enterprise Value57.60B $
Revenue (TTM)6.11B $
Gross Profit2.41B $
Net Income (TTM)251.38M $
Revenue/Share13.17 USD
Last Price90.67 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees542
CountryUS
SectorReal Estate
IndustryREIT - Healthcare Facilities
ISINUS92276F1003
Valuation
P/E (Trailing)164.84
P/E (Forward)108.35
PEG1.72
EV/EBITDA25.17
EV/Revenue9.42
P/S7.30
P/B3.40
EPS (TTM)0.55
EPS (Forward)0.85
52W Range
62.4788% of range94.60
52W High94.60 USD
52W Low62.47 USD
Profitability
Gross Margin41.38%
Oper. Margin13.77%
EBITDA Margin37.44%
Profit Margin4.31%
ROE2.01%
ROA0.91%
Growth
Revenue Growth21.90%
Earnings Growth10.00%
Cash Flow & Leverage
Operating CF1.65B $
CapEx (TTM)644.62M $
FCF Margin24.26%
FCF Yield3.36%
Net Debt12.54B $
Net Debt/EBITDA5.48
Balance Sheet
Debt/Equity1.06
Current Ratio0.21
Quick Ratio0.19
Book Value/Sh27.00 USD
Cash/Share0.3780 USD
Dividends
Fwd Div Rate2.000 USD
Trail. Div Rate1.960 USD
Div. Yield2.16%
5Y Avg Yield3.31%
Payout Ratio356.36%
Ex-Div DateJun 30, 2026
Pay DateJul 16, 2026
Splits
Last Split8757:10000
Split DateAug 18, 2015
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)97.18 USD
Upside (mean)+7.2%
Target Range86.00 USD – 110.00 USD
$86.00+7.2% to mean$110.00
# Analysts22
Ownership
Shares Out.486.17M
Float483.70M
Insiders0.53%
Institutions106.90%
Short Interest
Short Ratio6.0d
Short % Float5.46%
Short % Out.4.72%
Shares Short22.96M
Short (prev mo.)22.11M
Technical
SMA 5086.56 (+4.8%)
SMA 20080.69 (+12.4%)
Beta0.72
S&P 52W Chg20.11%
Avg Vol (30d)2.59M
Avg Vol (10d)4.38M
Technical Indicators
RSI (14)58.5
MACD2.0433
MACD Signal1.5399
MACD Hist.+0.5034
BB Upper95.48 USD
BB Middle87.62 USD
BB Lower79.76 USD
BB Width17.94%
ATR (14)2.041 USD
Vol Ratio (20d)0.58x